0001144204-16-125866.txt : 20160928 0001144204-16-125866.hdr.sgml : 20160928 20160928210019 ACCESSION NUMBER: 0001144204-16-125866 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160926 FILED AS OF DATE: 20160928 DATE AS OF CHANGE: 20160928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: New York STATE: NY ZIP: 10011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shapiro David CENTRAL INDEX KEY: 0001559570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 161908182 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES ST. CITY: NEW YORK STATE: NY ZIP: 10013 4 1 v449570_4.xml OWNERSHIP DOCUMENT X0306 4 2016-09-26 0 0001270073 INTERCEPT PHARMACEUTICALS INC ICPT 0001559570 Shapiro David C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH STREET, SUITE 505 NEW YORK NY 10011 0 1 0 0 CMO and EVP - Development Common Stock 2016-09-26 4 S 0 2659 164.7601 D 45732 D Common Stock 2016-09-26 4 S 0 886 166.03 D 44846 D The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person. This transaction was executed in multiple trades at prices ranging from $164.5201 to $165.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Bryan Yoon, as attorney-in-fact 2016-09-28